Vanguard Personalized Indexing Management LLC Invests $351,000 in ICU Medical, Inc. (NASDAQ:ICUI)

Vanguard Personalized Indexing Management LLC purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI) during the fourth quarter, HoldingsChannel reports. The firm purchased 3,524 shares of the medical instruments supplier’s stock, valued at approximately $351,000.

Other hedge funds have also added to or reduced their stakes in the company. WCM Investment Management LLC lifted its position in ICU Medical by 37.5% during the fourth quarter. WCM Investment Management LLC now owns 242,808 shares of the medical instruments supplier’s stock worth $24,223,000 after acquiring an additional 66,221 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in ICU Medical by 417.8% in the 4th quarter. State of Alaska Department of Revenue now owns 12,475 shares of the medical instruments supplier’s stock valued at $1,244,000 after purchasing an additional 10,066 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in ICU Medical by 7.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 168,957 shares of the medical instruments supplier’s stock valued at $20,108,000 after buying an additional 11,364 shares in the last quarter. Maryland State Retirement & Pension System bought a new position in ICU Medical during the 4th quarter worth $890,000. Finally, Louisiana State Employees Retirement System acquired a new stake in shares of ICU Medical during the fourth quarter worth $1,007,000. Institutional investors and hedge funds own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, KeyCorp raised their price target on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th.

ICU Medical Price Performance

Shares of NASDAQ ICUI opened at $101.68 on Monday. The business has a fifty day moving average price of $100.94 and a two-hundred day moving average price of $97.58. The stock has a market capitalization of $2.48 billion, a PE ratio of -41.50 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. ICU Medical, Inc. has a fifty-two week low of $78.28 and a fifty-two week high of $196.57.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.06. The company had revenue of $566.66 million for the quarter, compared to analysts’ expectations of $553.15 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. As a group, equities analysts predict that ICU Medical, Inc. will post 3.5 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Elisha W. Finney sold 300 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the transaction, the director now directly owns 2,129 shares in the company, valued at approximately $223,438.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Elisha W. Finney sold 300 shares of ICU Medical stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $104.95, for a total value of $31,485.00. Following the transaction, the director now owns 2,129 shares in the company, valued at approximately $223,438.55. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Ben Sousa sold 2,000 shares of the business’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $105.55, for a total value of $211,100.00. Following the transaction, the insider now directly owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The disclosure for this sale can be found here. Insiders have sold 26,562 shares of company stock worth $2,788,117 over the last ninety days. Corporate insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.